This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Inovalon Holdings (INOV) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Inovalon Holdings (INOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CTG or INOV: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CTG vs. INOV: Which Stock Is the Better Value Option?
Inovalon Holdings (INOV) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Inovalon Holdings (INOV) delivered earnings and revenue surprises of 44.44% and 0.57%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Inovalon Holdings (INOV) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Inovalon Holdings (INOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Buy Stocks for Jun 12th
by Nitish Marwah
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.
Inovalon Holdings (INOV) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Inovalon Holdings (INOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Outlook for Computer IT Services Industry Appears Bright
by Radhika Pujara
Robust adoption of modernized IT-service infrastructure solutions and increasing IT-spending trends favor growth prospects of the Computer-IT Services industry.
Inovalon Holdings (INOV) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Inovalon Holdings (INOV) delivered earnings and revenue surprises of -44.44% and -7.05%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Inovalon Holdings (INOV) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Inovalon Holdings (INOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inovalon (INOV) in Focus: Stock Moves 6% Higher
by Zacks Equity Research
Inovalon (INOV) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Inovalon Holdings (INOV) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Inovalon Holdings (INOV) delivered earnings and revenue surprises of -8.33% and -8.97%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Inovalon Holdings (INOV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Inovalon Holdings (INOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TransUnion Inks Deal to Buy Rubixis, Boosts Healthcare Suite
by Zacks Equity Research
The deal to acquire Rubixis is expected to boost TransUnion (TRU) Healthcare's portfolio.
Nutanix (NTNX) in Focus: Stock Moves 6.9% Higher
by Zacks Equity Research
Nutanix (NTNX) shares rose nearly 7% in the last trading session, amid huge volumes.
Unisys Corporation (UIS) Catches Eye: Stock Jumps 9.3%
by Zacks Equity Research
Unisys Corporation (UIS) shares rose more than 9% in the last trading session, amid huge volumes.
GTT Communications (GTT) in Focus: Stock Moves 7.2% Higher
by Zacks Equity Research
GTT Communications (GTT) shares rose more than 7% in the last trading session, amid huge volumes.
Inovalon Holdings (INOV) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Inovalon Holdings (INOV) delivered earnings and revenue surprises of 62.50% and 4.46%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Inovalon Holdings' ONE Platform Chosen by UnitedHealthcare
by Zacks Equity Research
Inovalon Holding (INOV) will be able to expand in the population health management space through the selection of its proprietary ONE Platform by UnitedHealthcare.
Inovalon (INOV) Jumps: Stock Rises 16.7%
by Zacks Equity Research
Inovalon (INOV) shares rose nearly 17% in the last trading session, amid huge volumes.
ServiceNow (NOW) Gains Despite Wider-than-Expected Loss in Q1
by Zacks Equity Research
ServiceNow Inc (NOW) reported reported loss of 18 cents per share in the first-quarter 2017, which was wider than the Zacks Consensus Estimate of a loss of 16 cents.
Why Inovalon Holdings (INOV) Could Be Positioned for a Surge
by Zacks Equity Research
Inovalon Holdings (INOV) could be good choice for investors as it is seeing decent short-term momentum and positive earnings estimate revisions.
Inovalon (INOV) Q4 Earnings In Line, Revenue Beat Estimates
by Zacks Equity Research
Inovalon Holdings, Inc. (INOV) reported fourth-quarter 2016 adjusted earnings of 2 cents per share, which came in line with the Zacks Consensus Estimate.
Anthem Extends Alliance with Inovalon, Boosts Customer Value
by Zacks Equity Research
Leading U.S.-based Health Maintenance Organization (HMO), Anthem Inc. (ANTM), recently declared a multi-year extension of its partnership with Inovalon Holdings, Inc. (INOV).
Inovalon (INOV) Cuts 2016 Revenue and Earnings Guidance
by Zacks Equity Research
Inovalon Holdings (INOV), lowered its revenue and earnings guidance for full-year 2016.